Background Haemato-oncology patients are likely to be referred later to palliative care than
patients with solid tumours, despite experiencing similar symptom burden. Patients prior to …

Introduction: Despite advances in palliative care management of physical, psychological,
and emotional symptoms along the spectrum of chronic conditions, early palliative care …

Purpose/Objectives: To quantify the characteristics of patients who die in the hospital from
relapse after allogeneic hematopoietic stem cell transplantation (alloHSCT), explore …

Purpose Patients with haematologic malignancies have less access to palliative care and
are referred later than patients with solid tumours. We developed a survey to investigate this …

The patients' perspective needs to be involved in future research to examine whether the
connotation of 'palliative care'is a barrier for patients, families or healthcare professionals …

Palliative care during and following allogeneic hematopoieti... : Current Opinion in Supportive
and Palliative Care Palliative care during and following allogeneic hematopoietic stem cell …

Introduction: Early integration between palliative care and other medical specialties in the
care of patients with serious illnesses is consolidating itself as good medical practice, based …

Objectives To provide support for the early integration of palliative care into the care of
hematopoietic cell transplant (HCT) recipients and families with the goal of improving care …

Objectives Early palliative care leads to meaningful improvements in physical and
psychosocial symptoms, as well as quality of life, in patients with advanced cancer. Patients …

Introduction Although allogeneic stem cell transplantation (allo-SCT) is a curative treatment
for many haematological malignancies, it is often associated with a high morbidity and …